Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures

Journal of Neuroinflammation

Volumn 6, Issue , 2009, Pages

  Lisak, Robert P ^a,b   Benjamins, Joyce A ^a,b   Bealmear, Beverly ^a   Nedelkoska, Liljana ^a   Studzinski, Diane ^a,d   Retland, Ernest ^a   Yao, Bin ^b,c   Land, Susan ^b,c  

^a DETROIT RECEIVING HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; DIACYLGLYCEROL; DOPAMINE 3 RECEPTOR; GLYCOPROTEIN P; INDUCIBLE NITRIC OXIDE SYNTHASE; ION; MULTIDRUG RESISTANCE PROTEIN 1; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR 5; PHOSPHATIDYLINOSITOL; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VITAMIN D; CYTOKINE; NERVE GROWTH FACTOR; NEUROPEPTIDE Y5 RECEPTOR; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION REGULATION; GLIA CELL; HOMEOSTASIS; LIPID METABOLISM; MACROPHAGE FUNCTION; METABOLIC REGULATION; MICROARRAY ANALYSIS; MITOCHONDRIAL RESPIRATION; MIXED CELL CULTURE; MONOCYTE; NERVE CELL CULTURE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UNINDEXED SEQUENCE; VITAMIN D METABOLISM; ANIMAL; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DNA MICROARRAY; DRUG EFFECT; MACROPHAGE; METABOLISM; MICROGLIA;

ANIMALS; ARGINASE; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CYTOKINES; DIGLYCERIDES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICROGLIA; NERVE GROWTH FACTORS; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P-GLYCOPROTEIN; RATS; RECEPTORS, DOPAMINE D3; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS;

EID: 60749126977     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-6-4     Document Type: Article

References (220)

1. Whitney LW Becker KG Tresser NJ Caballero-Ramos CI Munson PJ Prabhu VV Trent JM McFarland HF Biddison WE Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays Ann Neurol 1999, 46:425-428. 10.1002/ 1531-8249(199909)46:3<425::AID-ANA22>3.0.CO;2-O 10482277
2. Lock C Hermans G Pedotti R Brendolan A Schadt E Garren H Langer-Gould A Strober S Cannella B Allard J et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis Nat Med 2002, 8:500-508. 10.1038/nm0502-500 11984595
3. Tajouri L Mellick AS Ashton KJ Tannenberg AE Nagra RM Tourtellotte WW Griffiths LR Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis Brain Res Mol Brain Res 2003, 119:170-183. 10.1016/ j.molbrainres.2003.09.008 14625084
4. Mycko MP Papoian R Boschert U Raine CS Selmaj KW cDNA microarray analysis in multiple sclerosis lesions: Detection of genes associated with disease activity Brain 2003, 126:1048-1057. 10.1093/brain/awg107 12690045
5. Mycko MP Papoian R Boschert U Raine CS Selmaj KW Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis Clin Neurol Neurosurg 2004, 106:223-229. 10.1016/ j.clineuro.2004.02.019 15177772
6. Lindberg RL De Groot CJ Certa U Ravid R Hoffmann F Kappos L Leppert D Multiple sclerosis as a generalized CNS disease - comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS J Neuroimmunol 2004, 152:154-167. 10.1016/ j.jneuroim.2004.03.011 15223248
7. Allen IV McQuaid S Mirakhur M Nevin G Pathological abnormalities in the normal-appearing white matter in multiple sclerosis Neurol Sci 2001, 22:141-144. 10.1007/s100720170012 11603615
8. Allen IV McKeown SR A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis J Neurol Sci 1979, 41:81-91. 10.1016/0022-510X(79)90142-4 438845
9. Graumann U Reynolds R Steck AJ Schaeren-Wiemers N Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective me chanisms against hypoxic insult Brain Pathol 2003, 13:554-573. 14655760
10. Dutta R McDonough J Yin X Peterson J Chang A Torres T Gudz T Macklin WB Lewis DA Fox RJ et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients Ann Neurol 2006, 57:478-489. 10.1002/ana.20736
11. Dutta R McDonough J Chang A Swamy L Siu A Kidd GJ Rudick R Mirnics K Trapp BD Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients Brain 2007, 130:2566-2576. 10.1093/brain/awm206 17898009
12. Mahad D Ziabreva I Lassmann H Turnbull D Mitochondrial defects in acute multiple sclerosis lesions Brain 2008, 131:1722-1735. 2442422 18515320 10.1093/brain/awn105
13. Lisak R Studzinski D Bealmear B Nedelkoska L Benjamins J Kinetics of gene expression in central nervous system glial cells induced by Th1, Th2 and monocyte/macrophage cytokines Mult Scler 2005, 11(Suppl 2):S136-S137.
14. Lisak R Studzinski D Bealmear B Nedelkoska L Benjamins J Regulation of genes for neurotrophins and their receptors in central nervous system mixed glial cell cultures by mixtures of cytokines Mult Scler 2007, 13:S219. 18088439 2228280
15. Lisak R Benjamins J Bealmear B Yao B Land S Skundric DS Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for mmune-related molecules by central nervous system mixed glial cell cultures Mult Scler 2006, 12:149-168. 10.1191/ 135248506ms1251oa 16629418
16. Lisak RP Benjamins JA Bealmear B Nedelkoska L Yao B Land S Studzinski D Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: Neurotrophins, growth factors and structural proteins J Neuroinflammation 2007, 4:30. 2228280 18088439 10.1186/1742-2094-4-30
17. Nicot A Ratnakar PV Ron Y Chen CC Elkabes S Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction Brain 2003, 126:398-412. 10.1093/brain/awg041 12538406
18. Gallo V Patneau DK Mayer ML Vaccarino FM Excitatory amino acid receptors in glial progenitor cells: Molecular and functional properties Glia 1994, 11:94-101. 10.1002/glia.440110204 7927651
19. Gallo V Zhou JM McBain CJ Wright P Knutson PL Armstrong RC Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block J Neurosci 1996, 16:2659-2670. 8786442
20. Gallo V Ghiani CA Glutamate receptors in glia: New cells, new inputs and new functions Trends Pharmacol Sci 2000, 21:252-258. 10.1016/ S0165-6147(00)01494-2 10871893
21. Soliven B Calcium signalling in cells of oligodendroglial lineage Microsc Res Tech 2001, 52:672-679. 10.1002/jemt.1051 11276119
22. Kim WT Rioult MG Cornell-Bell AH Glutamate-induced calcium signaling in astrocytes Glia 1994, 11:173-184. 10.1002/glia.440110211 7927645
23. Pocock JM Kettenmann H Neurotransmitter receptors on microglia Trends Neurosci 2007, 30:527-535. 10.1016/j.tins.2007.07.007 17904651
24. Fields RD Stevens B ATP: An extracellular signaling molecule between neurons and glia Trends Neurosci 2000, 23:625-633. 10.1016/ S0166-2236(00)01674-X 11137153
25. McCarthy KD de Vellis J Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue J Cell Biol 1980, 85:890-902. 2111442 6248568 10.1083/jcb.85.3.890
26. Dyer CA Benjamins JA Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture J Neurosci 1988, 8:4307-4318. 2460596
27. Lisak RP Bealmear B Nedelkoska L Benjamins JA Secretory products of central nervous system glial cells induce Schwann cell proliferation and protect from cytokine-mediated death J Neurosci Res 2006, 83:1425-1431. 10.1002/jnr.20851 16583376
28. Raff MC Mirsky R Fields KL Lisak RP Dorfman SH Silberberg DH Gregson NA Leibowitz S Kennedy MC Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture Nature 1978, 274:813-816. 355894
29. Ranchst B Clapshaw PA Price J Noble M Seifert W Development of oligodendrocytes with a monoclonal antibody against galactocerebroside Proc Natl Acad Sci USA 1982, 79:2709-2713. 346271 7045870 10.1073/ pnas.79.8.2709
30. Eisenbarth GS Walsh FS Nirenberg M Monoclonal antibody to a plasma membrane antigen of neurons Proc Natl Acad Sci USA 1979, 76:4913-4917. 413048 388422 10.1073/pnas.76.10.4913
31. Dijkstra CD Van Vliet E Dopp EA Lelij van der AA Kraal G Marginal zone macrophages identified by a monoclonal antibody: Characterization of immuno- and enzyme-histochemical properties and functional capacities Immunology 1985, 55:23-30. 1453576 3888828
32. Mirsky R Thompson EJ Thy 1 (theta) antigen on the surface of morphologically distinct brain cell types Cell 1975, 4:95-101. 10.1016/ 0092-8674(75)90114-2 1092469
33. Pruss RM Thy-1 antigen on astrocytes in long-term cultures of rat central nervous system Nature 1979, 280:688-690. 10.1038/280688a0 471047
34. Sternberger LA Harwell LW Sternberger NH Neurotypy: Regional individuality in rat brain detected by immunocytochemistry with monoclonal antibodies Proc Natl Acad Sci USA 1982, 79:1326-1330. 345956 7041117 10.1073/pnas.79.4.1326
35. Kim HJ Ifergan I Antel JP Seguin R Duddy M Lapierre Y Jalili F Bar-Or A Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis J Immunol 2004, 172:7144-7153. 15153538
36. Liu Y Teige I Birnir B Issazadeh-Navikas S Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE Nat Med 2006, 12:518-525. 10.1038/nm1402 16633347
37. Baecher-Allan C Wolf E Hafler DA Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells Clin Immunol 2005, 115:10-18. 10.1016/j.clim.2005.02.018 15870015
38. Beg AA Baltimore D An essential role for NF-kappaB in preventing TNF-alpha-induced cell death [see comments] Science 1996, 274:782-784. 10.1126/science.274.5288.782 8864118
39. Li C Wong WH Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection Proc Natl Acad Sci USA 2001, 98:31-36. 14539 11134512 10.1073/pnas.011404098
40. Yao B Rakhade SN Li Q Ahmed S Krauss R Draghici S Loeb JA Accuracy of cDNA microarray methods to detect small gene expression changes induced by neuregulin on breast epithelial cells BMC Bioinformatics 2004, 5:99. 509237 15272935 10.1186/1471-2105-5-99
41. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001, 25:402-408. 10.1006/meth.2001.1262 11846609
42. Parpura V Basarsky TA Liu F Jeftinija K Jeftinija S Haydon PG Glutamate-mediated astrocyte-neuron signalling Nature 1994, 369:744-747. 10.1038/369744a0 7911978
43. Lehre KP Levy LM Ottersen OP Storm-Mathisen J Danbolt NC Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations J Neurosci 1995, 15:1835-1853. 7891138
44. Porter JT McCarthy KD Astrocytic neurotransmitter receptors in situ and in vivo Prog Neurobiol 1997, 51:439-455. 10.1016/S0301-0082(96)00068-8 9106901
45. Biber K Laurie DJ Berthele A Sommer B Tolle TR Gebicke-Harter PJ van Calker D Boddeke HW Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia J Neurochem 1999, 72:1671-1680. 10.1046/j.1471-4159.1999.721671.x 10098876
46. Pitt D Nagelmeier IE Wilson HC Raine CS Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis Neurology 2003, 61:1113-1120. 14581674
47. Pitt D Werner P Raine CS Glutamate excitotoxicity in a model of multiple sclerosis Nat Med 2000, 6:67-70. 10.1038/71555 10613826
48. Werner P Pitt D Raine CS Glutamate excitotoxicity - a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis? J Neural Transm Suppl 2000, 60:375-385. 11205156
49. Werner P Pitt D Raine CS Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage Ann Neurol 2001, 50:169-180. 10.1002/ana.1077 11506399
50. Takahashi JL Giuliani F Power C Imai Y Yong VW Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity Ann Neurol 2003, 53:588-595. 10.1002/ana.10519 12730992
51. Flor PJ Battaglia G Nicoletti F Gasparini F Bruno V Neuroprotective activity of metabotropic glutamate receptor ligands Adv Exp Med Biol 2002, 513:197-223. 12575822
52. Matute C Sanchez-Gomez MV Martinez-Millan L Miledi R Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes Proc Natl Acad Sci USA 1997, 94:8830-8835. 23152 9238063 10.1073/pnas.94.16.8830
53. Matute C Alberdi E Domercq M Perez-Cerda F Perez-Samartin A Sanchez-Gomez MV The link between excitotoxic oligodendroglial death and demyelinating diseases Trends Neurosci 2001, 24:224-230. 10.1016/ S0166-2236(00)01746-X 11250007
54. Matute C Perez-Cerda F Multiple sclerosis: Novel perspectives on newly forming lesions Trends Neurosci 2005, 28:173-175. 10.1016/ j.tins.2005.01.006 15808350
55. Alberdi E Sanchez-Gomez MV Torre I Domercq M Perez-Samartin A Perez-Cerda F Matute C Activation of kainate receptors sensitizes oligodendrocytes to complement attack J Neurosci 2006, 26:3220-3228. 10.1523/JNEUROSCI.3780-05.2006 16554473
56. Sanchez-Gomez MV Matute C AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures Neurobiol Dis 1999, 6:475-485. 10.1006/nbdi.1999.0264 10600403
57. McDonald JW Althomsons SP Hyrc KL Choi DW Goldberg MP Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity Nat Med 1998, 4:291-297. 10.1038/nm0398-291 9500601
58. Geurts JJ Wolswijk G Bo L Valk Van Der P Polman CH Troost D Aronica E Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis Brain 2003, 126:1755-1766. 10.1093/brain/ awg179 12805104
59. Ankarcrona M Dypbukt JM Bonfoco E Zhivotovsky B Orrenius S Lipton SA Nicotera P Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function Neuron 1995, 15:961-973. 10.1016/0896-6273(95)90186-8 7576644
60. Castiglione M Mangano K Busceti CL Nicoletti FR et al. Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures J Neurosci 2002, 22:5403-5411. 12097492
61. Abbracchio MP Burnstock G Purinergic signalling: Pathophysiological roles Jpn J Pharmacol 1998, 78:113-145. 10.1254/jjp.78.113 9829617
62. Bianco F Ceruti S Colombo A Fumagalli M Ferrari D Pizzirani C Matteoli M Di Virgilio F Abbracchio MP Verderio C A role for P2X7 in microglial proliferation J Neurochem 2006, 99:745-758. 10.1111/ j.1471-4159.2006.04101.x 16836656
63. Yiangou Y Facer P Durrenberger P Chessell IP Naylor A Bountra C Banati RR Anand P COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord BMC Neurol 2006, 6:12. 1413551 16512913 10.1186/1471-2377-6-12
64. Narcisse L Scemes E Zhao Y Lee SC Brosnan CF The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes Glia 2005, 49:245-258. 2586293 15472991 10.1002/glia.20110
65. Wang Y Roman R Lidofsky SD Fitz JG Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation Proc Natl Acad Sci USA 1996, 93:12020-12025. 38176 8876255 10.1073/ pnas.93.21.12020
66. Rappold PM Lynd-Balta E Joseph SA P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain Brain Res 2006, 1089:171-178. 10.1016/j.brainres.2006.03.040 16635480
67. Bongarzone ER Howard SG Schonmann V Campagnoni AT Identification of the dopamine D3 receptor in oligodendrocyte precursors: Potential role in regulating differentiation and myelin formation J Neurosci 1998, 18:5344-5353. 9651217
68. Rosin C Colombo S Calver AA Bates TE Skaper SD Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation Glia 2005, 52:336-343. 10.1002/glia.20250 16078234
69. Wang H Yu M Ochani M Amella CA Tanovic M Susarla S Li JH Yang H Ulloa L Al-Abed Y et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation Nature 2003, 421:384-388. 10.1038/ nature01339 12508119
70. Shytle RD Mori T Townsend K Vendrame M Sun N Zeng J Ehrhart J Silver AA Sanberg PR Tan J Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors J Neurochem 2004, 89:337-343. 10.1046/ j.1471-4159.2004.02347.x 15056277
71. Nizri E Hamra-Amitay Y Sicsic C Lavon I Brenner T Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors Neuropharmacology 2006, 50:540-547. 10.1016/j.neuropharm.2005.10.013 16336980
72. Burghaus L Schutz U Krempel U Lindstrom J Schroder H Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patients Parkinsonism Relat Disord 2003, 9:243-246. 12781587
73. Soliven B Szuchet S Arnason BG Nelson DJ Expression and modulation of K+ currents in oligodendrocytes: Possible role in myelinogenesis Dev Neurosci 1989, 11:118-131. 10.1159/000111893 2663420
74. Black JA Westenbroek R Minturn JE Ransom BR Catterall WA Waxman SG soform-specific expression of sodium channels in astrocytes in vitro: immunocytochemical observations Glia 1995, 14:I133-144. 10.1002/ glia.44014020
75. Visentin S Levi G Protein kinase C involvement in the resting and interferon-gamma-induced K+ channel profile of microglial cells J Neurosci Res 1997, 47:233-241. 10.1002/ (SICI)1097-4547(19970201)47:3<233::AID-JNR1>3.0.CO;2-J 9039645
76. Attali B Wang N Kolot A Sobko A Cherepanov V Soliven B Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells J Neurosci 1997, 17:8234-8245. 9334399
77. Verkhratsky A Steinhauser C Ion channels in glial cells Brain Res Brain Res Rev 2000, 32:380-412. 10.1016/S0165-0173(99)00093-4 10760549
78. Soliven B Szuchet S Nelson D Tumor necrosis factor inhibits K+current expression in cultured oligodendrocytes J Membr Biol 1991, 124:127-137. 10.1007/BF01870457 1662283
79. Cameron JS Lhuillier L Subramony P Dryer SE Developmental regulation of neuronal K+ channels by target-derived TGF beta in vivo and in vitro Neuron 1998, 21:1045-1053. 10.1016/S0896-6273(00)80622-4 9856460
80. Iwagaki H Fuchimoto S Miyake M Aoki H Orita K Interferon-gamma activates the voltage-gated calcium channel in RPMI 4788 cells Biochem Biophys Res Commun 1988, 153:1276-1281. 10.1016/S0006-291X(88)81366-4 2455515
81. Norenberg W Gebicke-Haerter PJ Illes P Inflammatory stimuli induce a new K+ outward current in cultured rat microglia Neurosci Lett 1992, 147:171-174. 10.1016/0304-3940(92)90587-W 1491802
82. Smith KJ McDonald WI The pathophysiology of multiple sclerosis: The mechanisms underlying the production of symptoms and the natural history of the disease Philos Trans R Soc Lond B Biol Sci 1999, 354:1649-1673. 1692682 10603618 10.1098/rstb.1999.0510
83. Smith KJ Hall SM Factors directly affecting impulse transmission in inflammatory demyelinating disease: Recent advances in our understanding Curr Opin Neurol 2001, 14:289-298. 10.1097/00019052-200106000-00005 11371750
84. Smith KJ Kapoor R Hall SM Davies M Electrically active axons degenerate when exposed to nitric oxide Ann Neurol 2001, 49:470-476. 10.1002/ana.96 11310624
85. Waxman SG Nitric oxide and the axonal death cascade Ann Neurol 2003, 53:150-153. 10.1002/ana.10397 12557280
86. Craner MJ Lo AC Black JA Waxman SG Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination Brain 2003, 126:1552-1561. 10.1093/brain/awg153 12805113
87. Carmody RJ Hilliard B Maguschak K Chodosh LA Chen YH Genomic scale profiling of autoimmune inflammation in the central nervous system: The nervous response to inflammation J Neuroimmunol 2002, 133:95-107. 10.1016/S0165-5728(02)00366-1 12446012
88. Kapoor R Davies M Blaker PA Hall SM Smith KJ Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration Ann Neurol 2003, 53:174-180. 10.1002/ana.10443 12557283
89. Stys PK General mechanisms of axonal damage and its prevention J Neurol Sci 2005, 233:3-13. 10.1016/j.jns.2005.03.031 15899499
90. Stys PK Waxman SG Ransom BR Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter Ann Neurol 1991, 30:375-380. 10.1002/ana.410300309 1952825
91. Kalman B Leist TP A mitochondrial component of neurodegeneration in multiple sclerosis Neuromolecular Med 2003, 3:147-158. 10.1385/ NMM:3:3:147 12835510
92. Wulff H Calabresi PA Allie R Yun S Pennington M Beeton C Chandy KG The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS J Clin Invest 2003, 111:1703-1713. 156104 12782673
93. Gu C Casaccia-Bonnefil P Srinivasan A Chao MV Oligodendrocyte apoptosis mediated by caspase activation J Neurosci 1999, 19:3043-3049. 10191321
94. Bredesen DE Mehlen P Rabizadeh S Apoptosis and dependence receptors: A molecular basis for cellular addiction Physiol Rev 2004, 84:411-430. 10.1152/physrev.00027.2003 15044679
95. Lucchinetti C Bruck W Parisi J Scheithauer B Rodriguez M Lassmann H Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination [see comments] Ann Neurol 2000, 47:707-717. 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q 10852536
96. Peterson JW Bo L Mork S Chang A Trapp BD Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions Ann Neurol 2001, 50:389-400. 10.1002/ana.1123 11558796
97. Tomita Y Bilim V Hara N Kasahara T Takahashi K Role of IRF-1 and caspase-7 in IFN-gamma enhancement of Fas-mediated apoptosis in ACHN renal cell carcinoma cells Int J Cancer 2003, 104:400-408. 10.1002/ ijc.10956 12584735
98. Gross A McDonnell JM Korsmeyer SJ BCL-2 family members and the mitochondria in apoptosis Genes Dev 1999, 13:1899-1911. 10.1101/ gad.13.15.1899 10444588
99. Gross A Yin XM Wang K Wei MC Jockel J Milliman C Erdjument-Bromage H Tempst P Korsmeyer SJ Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death J Biol Chem 1999, 274:1156-1163. 10.1074/jbc.274.2.1156 9873064
100. Rigamonti D Sipione S Goffredo D Zuccato C Fossale E Cattaneo E Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing J Biol Chem 2001, 276:14545-14548. 10.1074/ jbc.C100044200 11278258
101. Gervais FG Singaraja R Xanthoudakis S Gutekunst CA Leavitt BR Metzler M Hackam AS Tam J Vaillancourt JP Houtzager V et al. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi Nat Cell Biol 2002, 4:95-105. 10.1038/ncb735 11788820
102. Engqvist-Goldstein AE Warren RA Kessels MM Keen JH Heuser J Drubin DG The actin-binding protein Hip1R associates with clathrin during early stages of endocytosis and promotes clathrin assembly in vitro J Cell Biol 2001, 154:1209-1223. 2150824 11564758 10.1083/jcb.200106089
103. Harjes P Wanker EE The hunt for huntingtin function: Interaction partners tell many different stories Trends Biochem Sci 2003, 28:425-433. 10.1016/S0968-0004(03)00168-3 12932731
104. Bence NF Sampat RM Kopito RR Impairment of the ubiquitin-proteasome system by protein aggregation Science 2001, 292:1552-1555. 10.1126/ science.292.5521.1552 11375494
105. Sharma MR Koc EC Datta PP Booth TM Spremulli LL Agrawal RK Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins Cell 2003, 115:97-108. 10.1016/ S0092-8674(03)00762-1 14532006
106. Kunst CB Mezey E Brownstein MJ Patterson D Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions Nat Genet 1997, 15:91-94. 10.1038/ng0197-91 8988176
107. Dringen R Kussmaul L Gutterer JM Hirrlinger J Hamprecht B The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells J Neurochem 1999, 72:2523-2530. 10.1046/ j.1471-4159.1999.0722523.x 10349863
108. Baud O Greene AE Li J Wang H Volpe JJ Rosenberg PA Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes J Neurosci 2004, 24:1531-1540. 10.1523/JNEUROSCI.3989-03.2004 14973232
109. Hirrlinger J Konig J Dringen R Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones J Neurochem 2002, 82:716-719. 10.1046/ j.1471-4159.2002.01082.x 12153495
110. Hirrlinger J Konig J Keppler D Lindenau J Schulz JB Dringen R The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress J Neurochem 2001, 76:627-636. 10.1046/j.1471-4159.2001.00101.x 11208926
111. Volk H Potschka H Loscher W Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables J Histochem Cytochem 2005, 53:517-531. 10.1369/jhc.4A6451.2005 15805426
112. Volk HA Burkhardt K Potschka H Chen J Becker A Loscher W Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures Neuroscience 2004, 123:751-759. 10.1016/j.neuroscience.2003.10.012 14706787
113. Volk HA Loscher W Multidrug resistance in epilepsy: Rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures Brain 2005, 128:1358-1368. 10.1093/brain/awh437 15716304
114. Juurlink BH Response of glial cells to ischemia: Roles of reactive oxygen species and glutathione Neurosci Biobehav Rev 1997, 21:151-166. 10.1016/S0149-7634(96)00005-X 9062938
115. Barker JE Bolanos JP Land JM Clark JB Heales SJ Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: implications for neuronal/astrocytic trafficking and neurodegeneration Dev Neurosci 1996, 18:391-396. 10.1159/000111432 8940610
116. Back SA Gan X Li Y Rosenberg PA Volpe JJ Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion J Neurosci 1998, 18:6241-6253. 9698317
117. Margalit A Hauser SD Zweifel BS Anderson MA Isakson PC Regulation of prostaglandin biosynthesis in vivo by glutathione Am J Physiol 1998, 274:R294-302. 9486284
118. Götschel F Kern C Lang S Sparna T Markmann C Schwager J McNelly S von Weizsäcker F Laufer S Hecht A Merfort I Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis Exp Cell Res 2008, 314:1351-66. 10.1016/j.yexcr.2007.12.015 18261723
119. John GR Shankar SL Shafit-Zagardo B Massimi A Lee SC Raine CS Brosnan CF Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation Nat Med 2002, 8:1115-1121. 10.1038/ nm781 12357247
120. Stidworthy MF Genoud S Li WW Leone DP Mantei N Suter U Franklin RJ Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination Brain 2004, 127:1928-1941. 10.1093/brain/awh217 15289265
121. Cimini A Bernardo A Cifone G Di Muzio L Di Loreto S TNFalpha downregulates PPARdelta expression in oligodendrocyte progenitor cells: implications for demyelinating diseases Glia 2003, 41:3-14. 10.1002/ glia.10143 12465041
122. Feinstein DL Galea E Gavrilyuk V Brosnan CF Whitacre CC Dumitrescu-Ozimek L Landreth GE Pershadsingh HA Weinberg G Heneka MT Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis Ann Neurol 2002, 51:694-702. 10.1002/ana.10206 12112074
123. Natarajan C Bright JJ Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation Genes Immun 2002, 3:59-70. 10.1038/sj.gene.6363832 11960303
124. Saluja I Granneman JG Skoff RP PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture Glia 2001, 33:191-204. 10.1002/1098-1136(200103)33:3<191::AID-GLIA1018>3.0.CO;2-M 11241737
125. Satriotomo I Bowen KK Vemuganti R JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia J Neurochem 2006, 98:1353-1368. 10.1111/j.1471-4159.2006.04051.x 16923154
126. Tajouri L Mellick AS Tourtellotte A Nagra RM Griffiths LR An examination of MS candidate genes identified as differentially regulated in multiple sclerosis plaque tissue, using absolute and comparative real-time Q-PCR analysis Brain Res Brain Res Protoc 2005, 15:79-91. 10.1016/ j.brainresprot.2005.04.003 15905117
127. Xiao B Tu JC Worley PF Homer: A link between neural activity and glutamate receptor function Curr Opin Neurobiol 2000, 10:370-374. 10.1016/S0959-4388(00)00087-8 10851183
128. Rong R Ahn JY Huang H Nagata E Kalman D Kapp JA Tu J Worley PF Snyder SH Ye K PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis Nat Neurosci 2003, 6:1153-1161. 10.1038/ nn1134 14528310
129. Roche KW Tu JC Petralia RS Xiao B Wenthold RJ Worley PF Homer 1b regulates the trafficking of group I metabotropic glutamate receptors J Biol Chem 1999, 274:25953-25957. 10.1074/jbc.274.36.25953 10464340
130. Ango F Robbe D Tu JC Xiao B Worley PF Pin JP Bockaert J Fagni L Homer-dependent cell surface expression of metabotropic glutamate receptor type 5 in neurons Mol Cell Neurosci 2002, 20:323-329. 10.1006/ mcne.2002.1100 12093163
131. Osterhout DJ Wolven A Wolf RM Resh MD Chao MV Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase J Cell Biol 1999, 145:1209-1218. 2133143 10366594 10.1083/ jcb.145.6.1209
132. Liang X Draghi NA Resh MD Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes J Neurosci 2004, 24:7140-7149. 10.1523/JNEUROSCI.5319-03.2004 15306647
133. Galvin JE Lee VM Trojanowski JQ Synucleinopathies: Clinical and pathological implications Arch Neurol 2001, 58:186-190. 10.1001/ archneur.58.2.186 11176955
134. Cooper AA Gitler AD Cashikar A Haynes CM Hill KJ Bhullar B Liu K Xu K Strathearn KE Liu F {alpha}-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models Science 2006, 313:324-328. 1983366 16794039 10.1126/science.1129462
135. Kaplan B Ratner V Haas E Alpha-synuclein: Its biological function and role in neurodegenerative diseases J Mol Neurosci 2003, 20:83-92. 10.1385/JMN:20:2:83 12794302
136. Lee D Paik SR Choi KY Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein FEBS Lett 2004, 576:256-260. 10.1016/ j.febslet.2004.08.075 15474047
137. Richter-Landsberg C Gorath M Trojanowski JQ Lee VM alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes J Neurosci Res 2000, 62:9-14. 10.1002/ 1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U 11002283
138. Piao YS Mori F Hayashi S Tanji K Yoshimoto M Kakita A Wakabayashi K Takahashi H Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies Acta Neuropathol 2003, 105(4):403-409. 12624794
139. Brosnan CF Battistini L Gao YL Raine CS Aquino DA Heat shock proteins and multiple sclerosis: A review J Neuropathol Exp Neurol 1996, 55:389-402. 10.1097/00005072-199604000-00001 8786398
140. Stuve O Prod'homme T Slavin A Youssef S Dunn S Steinman L Zamvil SS Statins and their potential targets in multiple sclerosis therapy Expert Opin Ther Targets 2003, 7:613-622. 14498824
141. Neuhaus O Stuve O Archelos JJ Hartung HP Putative mechanisms of action of statins in multiple sclerosis - comparison to interferon-beta and glatiramer acetate J Neurol Sci 2005, 233:173-177. 10.1016/ j.jns.2005.03.030 15949504
142. Weber MS Youssef S Dunn SE Prod'homme T Neuhaus O Stuve O Greenwood J Steinman L Zamvil SS Statins in the treatment of central nervous system autoimmune disease J Neuroimmunol 2006, 178:140-148. 10.1016/ j.jneuroim.2006.06.006 16860400
143. Youssef S Stuve O Patarroyo JC Ruiz PJ Radosevich JL Hur EM Bravo M Mitchell DJ Sobel RA Steinman L Zamvil SS The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease Nature 2002, 420:78-84. 10.1038/nature01158 12422218
144. Nath N Giri S Prasad R Singh AK Singh I Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy J Immunol 2004, 172:1273-1286. 14707106
145. Greenwood J Walters CE Pryce G Kanuga N Beraud E Baker D Adamson P Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis Faseb J 2003, 17:905-907. 12626426
146. Gong JS Kobayashi M Hayashi H Zou K Sawamura N Fujita SC Yanagisawa K Michikawa M Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice J Biol Chem 2002 277 29919 29926 10.1074/jbc.M203934200 12042316
147. Tanaka Y Yamada K Zhou CJ Ban N Shioda S Inagaki N Temporal and spatial profiles of ABCA2-expressing oligodendrocytes in the developing rat brain J Comp Neurol 2003, 455:353-367. 10.1002/cne.10493 12483687
148. Chakraborty G Reddy R Drivas A Ledeen RW Interleukin-2 receptors and interleukin-2-mediated signaling in myelin: Activation of diacylglycerol kinase and phosphatidylinositol 3-kinase Neuroscience 2003, 122:967-973. 10.1016/j.neuroscience.2003.09.003 14643763
149. Sarkar S Floto RA Berger Z Imarisio S Cordenier A Pasco M Cook LJ Rubinsztein DC Lithium induces autophagy by inhibiting inositol monophosphatase J Cell Biol 2005, 170:1101-1111. 2171537 16186256 10.1083/jcb.200504035
150. Bedlack RS Maragakis N Heiman-Patterson T Lithium may slow progression of amyotrophic lateral sclerosis, but further study is needed Proc Natl Acad Sci USA 2008, 105:E17. author reply E18 2329692 18417448 10.1073/ pnas.0801762105
151. Fornai F Longone P Ferrucci M Lenzi P Isidoro C Ruggieri S Paparelli A The multiple roles of lithium Autophagy 2008, 4:T527-530.
152. Fornai F Longone P Cafaro L Kastsiuchenka O Ferrucci M Manca ML Lazzeri G Spalloni A Bellio N Lenzi P et al. Lithium delays progression of amyotrophic lateral sclerosis Proc Natl Acad Sci USA 2008, 105:2052-2057. 2538879 18250315 10.1073/pnas.0708022105
153. Chalfant CE Spiegel S Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling J Cell Sci 2005, 118:4605-4612. 10.1242/jcs.02637 16219683
154. Kappos L Antel J Comi G Montalban X O'Connor P Polman CH Haas T Korn AA Karlsson G Radue EW Oral fingolimod (FTY720) for relapsing multiple sclerosis N Engl J Med 2006, 355:1124-1140. 10.1056/NEJMoa052643 16971719
155. Singer II Tian M Wickham LA Lin J Matheravidathu SS Forrest MJ Mandala S Quackenbush EJ Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes J Immunol 2005, 175:7151-7161. 16301618
156. Yopp AC Ochando JC Mao M Ledgerwood L Ding Y Bromberg JS Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells J Immunol 2005, 175:2913-2924. 16116177
157. Lee MJ Van Brocklyn JR Thangada S Liu CH Hand AR Menzeleev R Spiegel S Hla T Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1 Science 1998, 279:1552-1555. 10.1126/ science.279.5356.1552 9488656
158. Hla T Signaling and biological actions of sphingosine 1-phosphate Pharmacol Res 2003, 47:401-407. 10.1016/S1043-6618(03)00046-X 12676514
159. Czeloth N Bernhardt G Hofmann F Genth H Forster R Sphingosine-1-phosphate mediates migration of mature dendritic cells J Immunol 2005, 175:2960-2967. 16116182
160. Cyster JG Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs Annu Rev Immunol 2005, 23:127-159. 10.1146/ annurev.immunol.23.021704.115628 15771568
161. Toman RE Spiegel S Lysophospholipid receptors in the nervous system Neurochem Res 2002, 27:619-627. 10.1023/A:1020219915922 12374197
162. Hida H Nagano S Takeda M Soliven B Regulation of mitogen-activated protein kinases by sphingolipid products in oligodendrocytes J Neurosci 1999, 19:7458-7467. 10460252
163. Pebay A Toutant M Premont J Calvo CF Venance L Cordier J Glowinski J Tence M Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades Eur J Neurosci 2001, 13:2067-2076. 10.1046/j.0953-816x.2001.01585.x
164. Mullershausen F Craveiro LM Shin Y Cortes-Cros M Bassilana F Osinde M Wishart WL Guerini D Thallmair M Schwab ME et al. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors J Neurochem 2007, 102:1151-1161. 10.1111/j.1471-4159.2007.04629.x 17488279
165. Miron VE Jung CG Kim HJ Kennedy TE Soliven B Antel JP FTY720 modulates human oligodendrocyte progenitor process extension and survival Ann Neurol 2008, 63:61-71. 10.1002/ana.21227 17918267
166. Ebert R Schutze N Adamski J Jakob F Vitamin D signaling is modulated on multiple levels in health and disease Mol Cell Endocrinol 2006, 248:149-159. 10.1016/j.mce.2005.11.039 16406653
167. Spach KM Pedersen LB Nashold FE Kayo T Yandell BS Prolla TA Hayes CE Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis Physiol Genomics 2004, 18:141-151. 10.1152/ physiolgenomics.00003.2004 15138306
168. Munger KL Zhang SM O'Reilly E Hernan MA Olek MJ Willett WC Ascherio A Vitamin D intake and incidence of multiple sclerosis Neurology 2004, 62:60-65. 14718698
169. Brown SJ The role of vitamin D in multiple sclerosis Ann Pharmacother 2006, 40:1158-1161. 10.1345/aph.1G513 16684809
170. Brosnan CF Battistini L Raine CS Dickson DW Casadevall A Lee SC Reactive nitrogen intermediates in human neuropathology: An overview Dev Neurosci 1994, 16:152-161. 10.1159/000112102 7535680
171. Smith KJ Lassmann H The role of nitric oxide in multiple sclerosis Lancet Neurol 2002, 1:232-241. 10.1016/S1474-4422(02)00102-3 12849456
172. Zhang J Cross AH McCarthy TJ Welch MJ Measurement of upregulation of inducible nitric oxide synthase in the experimental autoimmune encephalomyelitis model using a positron emitting radiopharmaceutical Nitric Oxide 1997, 1:263-267. 10.1006/niox.1997.0120 9704588
173. Bagasra O Michaels FH Zheng YM Bobroski LE Spitsin SV Fu ZF Tawadros R Koprowski H Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis Proc Natl Acad Sci USA 1995, 92:12041-12045. 40292 8618840 10.1073/pnas.92.26.12041
174. Hill KE Zollinger LV Watt HE Carlson NG Rose JW Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: Distribution, cellular expression and association with myelin damage J Neuroimmunol 2004, 151:171-179. 10.1016/j.jneuroim.2004.02.005 15145615
175. Boullerne AI Benjamins JA Nitric oxide synthase expression and nitric oxide toxicity in oligodendrocytes Antioxid Redox Signal 2006, 8:967-980. Review 10.1089/ars.2006.8.967 16771686
176. Waxman SG Craner MJ Black JA Na+ channel expression along axons in multiple sclerosis and its models Trends Pharmacol Sci 2004, 25:584-59. 10.1016/j.tips.2004.09.001 15491781
177. Hokfelt T Wiesenfeld-Hallin Z Villar M Melander T Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy Neurosci Lett 1987, 83:217-220. 10.1016/ 0304-3940(87)90088-7 2450311
178. Kashiba H Senba E Kawai Y Ueda Y Tohyama M Axonal blockade induces the expression of vasoactive intestinal polypeptide and galanin in rat dorsal root ganglion neurons Brain Res 1992, 577:19-28. 10.1016/ 0006-8993(92)90532-E 1381649
179. Shen PJ Larm JA Gundlach AL Expression and plasticity of galanin systems in cortical neurons, oligodendrocyte progenitors and proliferative zones in normal brain and after spreading depression Eur J Neurosci 2003, 18:1362-1376. 10.1046/j.1460-9568.2003.02860.x 14511317
180. Ubink R Calza L Hokfelt T 'Neuro'-peptides in glia: Focus on NPY and galanin Trends Neurosci 2003, 26:604-609. 10.1016/j.tins.2003.09.003 14585600
181. Holmes FE Mahoney S King VR Bacon A Kerr NC Pachnis V Curtis R Priestley JV Wynick D Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity Proc Natl Acad Sci USA 2000, 97:11563-11568. 17240 11016970 10.1073/pnas.210221897
182. Mahoney SA Hosking R Farrant S Holmes FE Jacoby AS Shine J Iismaa TP Scott MK Schmidt R Wynick D The second galanin receptor GalR2 plays a key role in neurite outgrowth from adult sensory neurons J Neurosci 2003, 23:416-421. 12533601
183. O'Meara G Coumis U Ma SY Kehr J Mahoney S Bacon A Allen SJ Holmes F Kahl U Wang FH et al. Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons Proc Natl Acad Sci USA 2000, 97:11569-11574. 17241 11016971 10.1073/pnas.210254597
184. Sahu A Xu B Kalra SP Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide Endocrinology 1994, 134:529-536. 10.1210/ en.134.2.529 7507825
185. Wynick D Small CJ Bacon A Holmes FE Norman M Ormandy CJ Kilic E Kerr NC Ghatei M Talamantes F et al. Galanin regulates prolactin release and lactotroph proliferation Proc Natl Acad Sci USA 1998, 95:12671-12676. 22889 9770544 10.1073/pnas.95.21.12671
186. Holmes FE Bacon A Pope RJ Vanderplank PA Kerr NC Sukumaran M Pachnis V Wynick D Transgenic overexpression of galanin in the dorsal root ganglia modulates pain-related behavior Proc Natl Acad Sci USA 2003, 100:6180-6185. 156346 12721371 10.1073/pnas.0937087100
187. Wiesenfeld-Hallin Z Xu XJ Villar MJ Hokfelt T Intrathecal galanin potentiates the spinal analgesic effect of morphine: electrophysiological and behavioural studies Neurosci Lett 1990, 109:217-221. 10.1016/0304-3940(90)90566-R 1690366
188. Nordstrom O Melander T Hokfelt T Bartfai T Goldstein M Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence Neurosci Lett 1987, 73:21-26. 10.1016/ 0304-3940(87)90024-3 2436097
189. Sundstrom E Archer T Melander T Hokfelt T Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze Neurosci Lett 1988, 88:331-335. 10.1016/0304-3940(88)90233-9 2455255
190. Hosli E Ledergerber M Kofler A Hosli L Evidence for the existence of galanin receptors on cultured astrocytes of rat CNS: Colocalization with cholinergic receptors J Chem Neuroanat 1997, 13:95-103. 10.1016/ S0891-0618(97)00024-0 9285354
191. Dugas JC Tai YC Speed TP Ngai J Barres BA Functional genomic analysis of oligodendrocyte differentiation J Neurosci 2006, 26:10967-10983. 10.1523/ JNEUROSCI.2572-06.2006 17065439
192. Brenner T Abramsky O Immunosuppression of experimental autoimmune myasthenia gravis by alpha-fetoprotein rich formation Immunol Lett 1981, 3:163-167. 10.1016/0165-2478(81)90121-8 6169635
193. Lubetzki-Korn I Hirayama M Silberberg DH Schreiber AD Eccleston PA Pleasure D Brenner T Abramsky O Human alpha-fetoprotein-rich fraction inhibits galactocerebroside antibody-mediated lysis of oligodendrocytes in vitro Ann Neurol 1984, 15:171-180. 10.1002/ana.410150210 6200057
194. Evron S Brenner T Abramsky O Suppressive effect of pregnancy on the development of experimental allergic encephalomyelitis in rabbits Am J Reprod Immunol 1984, 5:109-113. 6204544
195. Brenner T Evron S Soffer D Abramsky O Treatment of experimental allergic encephalomyelitis in rabbits with alpha-fetoprotein Isr J Med Sci 1985, 21:945-949. 2419277
196. Sanchez-Ramos J Song S Cardozo-Pelaez F Hazzi C Stedeford T Willing A Freeman TB Saporta S Janssen W Patel N et al. Adult bone marrow stromal cells differentiate into neural cells in vitro Exp Neurol 2000, 164:247-256. 10.1006/exnr.2000.7389 10915564
197. Gallo V Armstrong RC Developmental and growth factor-induced regulation of nestin in oligodendrocyte lineage cells J Neurosci 1995, 15:394-406. 7823144
198. Filippov V Kronenberg G Pivneva T Reuter K Steiner B Wang LP Yamaguchi M Kettenmann H Kempermann G Subpopulation of nestin-expressing progenitor cells in the adult murine hippocampus shows electrophysiological and morphological characteristics of astrocytes Mol Cell Neurosci 2003, 23:373-382. 10.1016/S1044-7431(03)00060-5 12837622
199. Almazan G Vela JM Molina-Holgado E Guaza C Re-evaluation of nestin as a marker of oligodendrocyte lineage cells Microsc Res Tech 2001, 52:753-765. 10.1002/jemt.1060 11276128
200. Brenneman DE Phillips TM Hauser J Hill JM Spong CY Gozes I Complex array of cytokines released by vasoactive intestinal peptide Neuropeptides 2003, 37:111-119. 10.1016/S0143-4179(03)00022-2 12747943
201. Gozes I Brenneman DE A new concept in the pharmacology of neuroprotection J Mol Neurosci 2000, 14:61-68. 10.1385/JMN:14:1-2:061 10854037
202. Wu L Iwai M Li Z Shiuchi T Min LJ Cui TX Li JM Okumura M Nahmias C Horiuchi M Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells Mol Endocrinol 2004, 18:666-678. 10.1210/me.2003-0053 14684844
203. Zhang X Lassila M Cooper ME Cao Z Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors Hypertension 2004, 43:276-281. 10.1161/ 01.HYP.0000113628.94574.0f 14718351
204. Sarlos S Rizkalla B Moravski CJ Cao Z Cooper ME Wilkinson-Berka JL Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin Am J Pathol 2003, 163:879-887. 1868261 12937129
205. Steinman L Zamvil S Transcriptional analysis of targets in multiple sclerosis Nat Rev Immunol 2003, 3:483-492. 10.1038/nri1108 12776208
206. Steinman L Gene microarrays and experimental demyelinating disease: A tool to enhance serendipity Brain 2001, 124:1897-1899. 10.1093/brain/ 124.10.1897 11571209
207. Passafaro M Sala C Niethammer M Sheng M Microtubule binding by CRIPT and its potential role in the synaptic clustering of PSD-95 Nat Neurosci 1999, 2:1063-1069. 10.1038/15990 10570482
208. Fukaya M Watanabe M Improved immunohistochemical detection of postsynaptically located PSD-95/SAP90 protein family by protease section pretreatment: A study in the adult mouse brain J Comp Neurol 2000, 426:572-586. 10.1002/ 1096-9861(20001030)426:4<572::AID-CNE6>3.0.CO;2-9 11027400
209. Klomp LW Gitlin JD Expression of the ceruloplasmin gene in the human retina and brain: Implications for a pathogenic model in aceruloplasminemia Hum Mol Genet 1996, 5:1989-1996. 10.1093/hmg/ 5.12.1989 8968753
210. Yoshida K Kaneko K Miyajima H Tokuda T Nakamura A Kato M Ikeda S Increased lipid peroxidation in the brains of aceruloplasminemia patients J Neurol Sci 2000, 175:91-95. 10.1016/S0022-510X(00)00295-1 10831768
211. Patel BN Dunn RJ Jeong SY Zhu Q Julien JP David S Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury J Neurosci 2002, 22:6578-6586. 12151537
212. Shin T Kim H Jin JK Moon C Ahn M Tanuma N Matsumoto Y Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis J Neuroimmunol 2005, 165:11-20. 10.1016/j.jneuroim.2005.03.019 15925413
213. Cai D Deng K Mellado W Lee J Ratan RR Filbin MT Arginase 1 and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro Neuron 2002, 35:711-719. 10.1016/ S0896-6273(02)00826-7 12194870
214. Hesse M Modolell M La Flamme AC Schito M Fuentes JM Cheever AW Pearce EJ Wynn TA Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: Granulomatous pathology is shaped by the pattern of L-arginine metabolism J Immunol 2001, 167:6533-6544. 11714822
215. Louis CA Mody V Henry WL Jr Reichner JS Albina JE Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages Am J Physiol 1999, 276:R237-242. 9887201
216. Mori M Gotoh T Regulation of nitric oxide production by arginine metabolic enzymes Biochem Biophys Res Commun 2000, 275:715-719. 10.1006/ bbrc.2000.3169 10973788
217. Estevez AG Sahawneh MA Lange PS Bae N Egea M Ratan RR Arginase 1 regulation of nitric oxide production is key to survival of trophic factor-deprived motor neurons J Neurosci 2006, 26:8512-8516. 2570095 16914676 10.1523/JNEUROSCI.0728-06.2006
218. Becker-Catania SG Gregory TL Yang Y Gau CL de Vellis J Cederbaum SD Iyer RK Loss of arginase I results in increased proliferation of neural stem cells J Neurosci Res 2006, 84:735-746. 10.1002/jnr.20964 16773651
219. Lassmann H Hypoxia-like tissue injury as a component of multiple sclerosis lesions J Neurol Sci 2003, 206:187-191. 10.1016/ S0022-510X(02)00421-5 12559509
220. Kirk SL Karlik SJ VEGF and vascular changes in chronic neuroinflammation J Autoimmun 2003, 21:353-363. 10.1016/S0896-8411(03)00139-2 14624758